Literature DB >> 17657220

ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.

M H G P Raaijmakers1.   

Abstract

ATP-binding-cassette (ABC) transporters are evolutionary extremely well-conserved transmembrane proteins that are highly expressed in hematopoietic stem cells (HSCs). The physiological function in human stem cells is believed to be protection against genetic damage caused by both environmental and naturally occurring xenobiotics. Additionally, ABC transporters have been implicated in the maintenance of quiescence and cell fate decisions of stem cells. These physiological roles suggest a potential role in the pathogenesis and biology of stem cell-derived hematological malignancies such as acute and chronic myeloid leukemia. This paper reviews the (patho)physiological role of ABC transporters in human normal and malignant HSCs and discusses its implications for their utility as therapeutical targets to eradicate leukemic stem cells in these diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657220     DOI: 10.1038/sj.leu.2404859

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  37 in total

1.  ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.

Authors:  Christophe Marzac; Edith Garrido; Ruoping Tang; Fanny Fava; Pierre Hirsch; Cinzia De Benedictis; Elise Corre; Simona Lapusan; Jean-Yves Lallemand; Jean-Pierre Marie; Eric Jacquet; Ollivier Legrand
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

2.  A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes.

Authors:  Anair Graciela Lema Fernandez; Barbara Crescenzi; Valentina Pierini; Valeria Di Battista; Gianluca Barba; Fabrizia Pellanera; Danika Di Giacomo; Giovanni Roti; Rocco Piazza; Emmalee R Adelman; Maria E Figueroa; Cristina Mecucci
Journal:  Leukemia       Date:  2019-03-28       Impact factor: 11.528

Review 3.  Age-related Deterioration of Hematopoietic Stem Cells.

Authors:  Mi Jung Kim; Min Hwan Kim; Seung Ah Kim; Jae Suk Chang
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

4.  CD133 expression in chemo-resistant Ewing sarcoma cells.

Authors:  Xiaohua Jiang; Ynnez Gwye; Darren Russell; Christine Cao; Dorothea Douglas; Long Hung; Heinrich Kovar; Timothy J Triche; Elizabeth R Lawlor
Journal:  BMC Cancer       Date:  2010-03-26       Impact factor: 4.430

5.  Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells.

Authors:  Leilei Tang; Saskia M Bergevoet; Christian Gilissen; Theo de Witte; Joop H Jansen; Bert A van der Reijden; Reinier A P Raymakers
Journal:  BMC Pharmacol       Date:  2010-09-13

Review 6.  Stem cells and aging in the hematopoietic system.

Authors:  Luigi A Warren; Derrick J Rossi
Journal:  Mech Ageing Dev       Date:  2008-04-08       Impact factor: 5.432

Review 7.  Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.

Authors:  Bryan P Toole; Mark G Slomiany
Journal:  Drug Resist Updat       Date:  2008-05-19       Impact factor: 18.500

8.  Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells.

Authors:  Hong Zhao; Toshiki Tanaka; Vadim Mitlitski; Julie Heeter; Endre A Balazs; Zbigniew Darzynkiewicz
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

9.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

10.  Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems.

Authors:  Sapan J Patel; Su Dao; Costel C Darie; Bayard D Clarkson
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.